- Home
- MIND vs BYSI Comparison
MIND vs BYSI Comparison
Compare MIND & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIND
- BYSI
- Stock Information
- Founded
- MIND 1987
- BYSI 2010
- Country
- MIND United States
- BYSI United States
- Employees
- MIND N/A
- BYSI N/A
- Industry
- MIND Industrial Machinery/Components
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- MIND Industrials
- BYSI Health Care
- Exchange
- MIND Nasdaq
- BYSI Nasdaq
- Market Cap
- MIND 67.5M
- BYSI 79.0M
- IPO Year
- MIND 1994
- BYSI 2017
- Fundamental
- Price
- MIND $8.66
- BYSI $1.93
- Analyst Decision
- MIND
- BYSI
- Analyst Count
- MIND 0
- BYSI 0
- Target Price
- MIND N/A
- BYSI N/A
- AVG Volume (30 Days)
- MIND 265.5K
- BYSI 22.2K
- Earning Date
- MIND 12-12-2025
- BYSI 11-12-2025
- Dividend Yield
- MIND N/A
- BYSI N/A
- EPS Growth
- MIND N/A
- BYSI N/A
- EPS
- MIND 2.54
- BYSI N/A
- Revenue
- MIND $48,612,000.00
- BYSI N/A
- Revenue This Year
- MIND $2.33
- BYSI N/A
- Revenue Next Year
- MIND N/A
- BYSI N/A
- P/E Ratio
- MIND $3.58
- BYSI N/A
- Revenue Growth
- MIND 27.70
- BYSI N/A
- 52 Week Low
- MIND $3.75
- BYSI $0.98
- 52 Week High
- MIND $14.50
- BYSI $3.44
- Technical
- Relative Strength Index (RSI)
- MIND 35.90
- BYSI 51.59
- Support Level
- MIND $8.49
- BYSI $1.70
- Resistance Level
- MIND $9.39
- BYSI $2.10
- Average True Range (ATR)
- MIND 0.99
- BYSI 0.20
- MACD
- MIND -0.52
- BYSI -0.02
- Stochastic Oscillator
- MIND 2.50
- BYSI 53.92
About MIND MIND Technology Inc. (DE)
MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.